Lie IA, Wesnes K, Kvistad SS, Brouwer I, Wergeland S, Holmøy T, Midgard R, Bru A, Edland A, Eikeland R, Gosal S, Harbo HF, Kleveland G, Sørenes YS, Øksendal N, Barkhof F, Vrenken H, Myhr KM, Bø L, Torkildsen Ø(2022) The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis Neurol Neuroimmunol Neuroinflamm, 9(5) DOI 10.1212/NXI.0000000000200008, PubMed 35738901
Drobnjak Nes D, Berg-Hansen P, de Rodez Benavent SA, Høgestøl EA, Beyer MK, Rinker DA, Veiby N, Karabeg M, Petrovski BÉ, Celius EG, Harbo HF, Petrovski G(2022) Exploring Retinal Blood Vessel Diameters as Biomarkers in Multiple Sclerosis J Clin Med, 11(11) DOI 10.3390/jcm11113109, PubMed 35683496
Brune S, Høgestøl EA, de Rodez Benavent SA, Berg-Hansen P, Beyer MK, Leikfoss IS, Bos SD, Sowa P, Brunborg C, Andorra M, Pulido Valdeolivas I, Asseyer S, Brandt A, Chien C, Scheel M, Blennow K, Zetterberg H, Kerlero de Rosbo N, Paul F, Uccelli A, Villoslada P, Berge T, Harbo HF(2022) Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis Mult Scler, 13524585221097296(in press) DOI 10.1177/13524585221097296, PubMed 35658739